Table: Cosmos Pharmaceutical - 6-MTH group results

Cosmos Pharmaceutical

12/01/2021 06:00

Jan 12 (Reuters)- 
             Cosmos Pharmaceutical Corp. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Nov 30, 2020        Nov 30, 2019     May 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            364.18              325.27           723.00    
                 (+12.0 pct)         (+9.0 pct)       (+5.6 pct)  
  Operating         18.29               11.97            29.10    
                 (+52.9 pct)         (-2.9 pct)       (+0.0 pct)  
  Recurring         19.55               13.11            31.60    
                 (+49.1 pct)         (-2.9 pct)       (+0.1 pct)  
  Net               13.07                8.77            21.78    
                 (+49.0 pct)         (-2.6 pct)       (+1.6 pct)  
  EPS            330.12 yen          221.50 yen       550.01 yen  
  Ann Div                            110.00 yen        55.00 yen  
  -Q2 div         27.50 yen           50.00 yen                   
  -Q4 div                             60.00 yen        27.50 yen  
  
  NOTE - Cosmos Pharmaceutical Corp.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T